Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-09-28
2000-09-12
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546256, 546194, 546261, 546193, 514318, 514335, C07D40112, A61K 314412
Patent
active
061178888
ABSTRACT:
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure:
REFERENCES:
patent: 5260307 (1993-11-01), Ackermann et al.
patent: 5405854 (1995-04-01), Ackermann et al.
patent: 5459142 (1995-10-01), Tone et al.
patent: 5510369 (1996-04-01), Lumma et al.
patent: 5744486 (1998-04-01), Sanderson et al.
patent: 5866573 (1999-02-01), Sanderson et al.
Bernstein, Peter R. et al, "Nonpeptidic Inhibitors of Human Leukocyte Elastase . . ."J. Med. Chem., vol. 37, pp. 3313-3326 (1994).
Sanderson, P. E., et al., "Preparation Of 3-Amino-2-Pyrazinone-1-Acetamide Derivatives As Thrombin Inhibitors," Chem. Abstr., vol. 128, No. 3, pp. 532 (1998).
Sanderson, et al., Preparation of Aminopyridones as Thrombin Inhibitors, Database Caplus on STN, No. 129:136100 (1998).
Cutrona Kellie
Sanderson Philip E.
Fan Jane
Merck & Co. , Inc.
Parr Richard S.
Winokur Melvin
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-96545